1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Creso Pharma Limited
  6. News
  7. Summary
    CPH   AU000000CPH2

CRESO PHARMA LIMITED

(CPH)
Delayed Australian Stock Exchange  -  01:52 2022-08-16 am EDT
0.0390 AUD    0.00%
07/29Creso Pharma Limited signed a non-binding term sheet to acquire Health House International Limited for AUD 5.3 million.
CI
07/22Creso Pharma's Canadian Subsidiary Secures Two Purchase Orders from New Supply Program
MT
07/18Creso Pharma's Canadian Subsidiary Seeks to Expand Scope of Upcoming Phase 2 Trial; Shares Jump 7%
MT
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Creso Pharma Signs Deal to Launch Cannabis Range for the Taiwanese Animal Healthcare Market

06/30/2022 | 02:22am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
CRESO PHARMA LIMITED 0.00% 0.039 Delayed Quote.-52.44%
FTSE TWSE TAIWAN 50 INDEX 0.09% 11993.42 Delayed Quote.-16.00%
MSCI TAIWAN (STRD) 0.08% 573.82 Real-time Quote.-23.43%
All news about CRESO PHARMA LIMITED
07/29Creso Pharma Limited signed a non-binding term sheet to acquire Health House Internatio..
CI
07/22Creso Pharma's Canadian Subsidiary Secures Two Purchase Orders from New Supply Program
MT
07/18Creso Pharma's Canadian Subsidiary Seeks to Expand Scope of Upcoming Phase 2 Trial; Sha..
MT
07/13CRESO PHARMA : Application for quotation of securities - CPH
PU
07/11Creso Pharma Signs Deal to Commercialize Animal Health Products in Korea
MT
07/11Creso Pharma Limited Signs Non-Binding, Non-Exclusive Letter of Intent with Providence ..
CI
07/07Australian Shares Rebound Amid Increase in Payroll Jobs
MT
07/06Creso Pharma, Gotro Global Enter Deal to Launch Sierra Sage Herbs Pet Care Products in ..
MT
07/06Creso Pharma Limited Signs Non-Binding, Non-Exclusive Heads of Agreement with Gotro Glo..
CI
06/30Creso Pharma Signs Deal to Launch Cannabis Range for the Taiwanese Animal Healthcare Ma..
MT
More news
Financials ()
Sales 2021 6,22 M - -
Net income 2021 -30,0 M - -
Net cash 2021 7,18 M - -
P/E ratio 2021 -3,02x
Yield 2021 -
Capitalization 55,7 M 39,1 M -
EV / Sales 2020 65,2x
EV / Sales 2021 15,0x
Nbr of Employees -
Free-Float 87,6%
Chart CRESO PHARMA LIMITED
Duration : Period :
Creso Pharma Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CRESO PHARMA LIMITED
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Managers and Directors
William Lay Chief Executive Officer, Director & MD
Chris Grundy Chief Financial Officer
James Anthony Ellingford Executive Chairman
Boaz Wachtel Executive Chairman
Adam Blumenthal Non-Executive Chairman
Sector and Competitors
1st jan.Capi. (M$)
CRESO PHARMA LIMITED-52.44%39
JOHNSON & JOHNSON-2.91%436 680
ELI LILLY AND COMPANY13.66%298 298
PFIZER, INC.-15.75%279 215
ROCHE HOLDING AG-16.14%277 502
ABBVIE INC.5.09%251 582